CI — Cell Impact AB (publ) Income Statement
0.000.00%
- SEK115.72m
- SEK150.78m
- SEK37.33m
Annual income statement for Cell Impact AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 29.3 | 81.8 | 76.8 | 47.3 | 37.3 |
| Cost of Revenue | |||||
| Gross Profit | 19.1 | 34.9 | 37.5 | 25.5 | 5.42 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 72.4 | 160 | 180 | 167 | 136 |
| Operating Profit | -43.1 | -78 | -103 | -119 | -99 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -44.3 | -79.7 | -104 | -121 | -100 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -44.3 | -79.9 | -104 | -121 | -100 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -44.3 | -79.9 | -104 | -121 | -100 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -44.3 | -79.9 | -104 | -121 | -100 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.51 | -2.47 | -2.52 | -1.19 | -0.909 |
| Dividends per Share |